Drug factory · FDA FEI 1000358697
Vantive Limited
2 Wavertree Boulevard, Liverpool, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Jun 17, 2016.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2016: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chlorid | Makes the active ingredient | Vantive US Healthcare LLC | 0941-0679 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 17, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.